{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/insect-bites-stings/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"274f3cb2-5abb-57f4-863b-305c047304d4","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 288ebb2f-e28a-4f87-80cd-47302f0c96e0 --><h2>Changes</h2><!-- end field 288ebb2f-e28a-4f87-80cd-47302f0c96e0 -->","summary":null,"htmlStringContent":"<!-- begin item 3c95b0e4-5396-4552-9194-92e9ce72881d --><!-- begin field f85e7905-068d-46ef-ab01-912779248e21 --><p><strong>September 2020 </strong>— minor update. Recommendations on follow up and expanded criteria for emergency referral added. Both these areas developed from the NICE <em>Insect and bites: antimicrobial prescribing</em> guideline 2020. </p><p><strong>September to October 2016</strong> — reviewed. A literature search was conducted in September 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. No major changes to recommendations have been made.</p><!-- end field f85e7905-068d-46ef-ab01-912779248e21 --><!-- end item 3c95b0e4-5396-4552-9194-92e9ce72881d -->","topic":{"id":"5fb51420-7dde-570a-9143-4430ce2c416f","topicId":"98d5228a-4316-48a5-b0b4-8ce593895b9b","topicName":"Insect bites and stings","slug":"insect-bites-stings","lastRevised":"Last revised in September 2020","chapters":[{"id":"b3987bd3-6df1-5312-ac15-39253a6e9153","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"c4a80df9-760d-5344-ad21-ad8a0e5123ae","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"feb894d2-51e0-5a95-80a4-a3d4d87a7a11","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"274f3cb2-5abb-57f4-863b-305c047304d4","slug":"changes","fullItemName":"Changes"},{"id":"fa348d47-ba96-5d20-921b-06d450880580","slug":"update","fullItemName":"Update"}]},{"id":"cef009de-1c13-5bb6-a9e2-f40936f73a2c","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"0867b614-4170-5dcc-9aa6-5ab899c98cc1","slug":"goals","fullItemName":"Goals"},{"id":"e20c3d56-e350-5ae8-a345-756ec19e594e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"3a14a621-3419-50d1-9b59-bfb7549630b0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9fc3bdff-0f68-5da4-849f-a5db700c1154","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3b6f998e-f3d9-5666-a790-c7e00cf61adb","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"8c2f1988-a51d-5f1d-a62e-c5b704e8d281","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b8655c44-cf6d-5f1e-a31d-7bd1be6b82b7","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"c9af0dad-3123-55f2-b776-4d223c8bc28b","slug":"definition","fullItemName":"Definition"},{"id":"51cbb2b1-d7c1-5bd7-819a-fce27f691172","slug":"causes","fullItemName":"Causes"},{"id":"3be99119-b420-5e14-8d88-bcf5e304a0e0","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0d871ac2-26ea-5a5f-8489-73263f145a48","slug":"complications","fullItemName":"Complications"},{"id":"38ea52b7-32aa-5bcd-90cc-a77a2d1aeabe","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"cc04d518-38d3-52d0-84c4-87a0341b4862","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"17339ffe-5f2a-5658-b2c3-627bc750ab14","slug":"assessment","fullItemName":"Assessment"},{"id":"7e1c8e1d-f8f9-5201-ac44-d465ccab3a83","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"fb023358-f66f-5691-bf41-42a663e78ad5","fullItemName":"Management","slug":"management","subChapters":[{"id":"4b66d5b9-2d9b-5dce-b233-d837c44f0fd6","slug":"admission","fullItemName":"Scenario: Admission"},{"id":"b967e966-bdd2-52d3-8824-947fb109923b","slug":"referral","fullItemName":"Scenario: Referral"},{"id":"5aa39057-d771-5f2b-91a4-c574a8379196","slug":"management-in-primary-care","fullItemName":"Scenario: Management in primary care"}]},{"id":"c56dd0ad-0ac1-5b56-885d-087afbc15288","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"cd867283-946c-5db4-ab8b-75182854263a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"6867d636-1636-5900-985a-e66a3b605491","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a3fec4e5-1496-5178-9876-390a6a96f5db","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"03327df5-e871-5720-99d8-a8867c3beff4","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"540d16e1-b22f-5e50-bea1-6fe322223876","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"e4e77474-8c85-5bae-bfea-0b24362c3547","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c16430f7-47ee-54ec-8c82-f7af24361c6c","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"feb894d2-51e0-5a95-80a4-a3d4d87a7a11","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"942c9a29-8844-517d-b818-22df66f12010","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field dba3dece-9d3c-4faf-8973-6f2a909aa991 --><h3>Previous changes</h3><!-- end field dba3dece-9d3c-4faf-8973-6f2a909aa991 -->","summary":null,"htmlStringContent":"<!-- begin item afcfeac6-ce7c-40b6-baf3-a51c93a27a0a --><!-- begin field b52e3a75-63b0-4abf-8f1a-6fb7560ec7f3 --><p><strong>May 2016 </strong>— minor update. Text updated to reflect the Medicines and Healthcare products Regulatory Agency safety update on the risk of QT interval prolongation and Torsade de Pointes with hydroxyzine.</p><p><strong>February 2013 </strong>— minor update. The 2013 QIPP options for local implementation have been added to this topic.</p><p><strong>October 2012 </strong>— minor update. The 2012 QIPP options for local implementation have been added to this topic.</p><p><strong>June 2012 </strong>— minor update. Minor typographical error corrected.</p><p><strong>October 2011 </strong>— reviewed. A literature search was conducted in October 2011 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of the topic. No changes to clinical recommendations have been made. Issued in November 2011.</p><p><strong>July 2011 </strong>— minor update. More exact paracetamol dosing for children has been introduced by the Medicines and Healthcare products Regulatory Agency. Prescriptions have been updated to reflect the revised dosing. Issued in July 2011.</p><p><strong>May 2011 </strong>— minor update. The 2010/2011 QIPP options for local implementation have been added to this topic. Issued in June 2011.</p><p><strong>March 2011 </strong>— topic structure revised to ensure consistency across CKS topics — no changes to clinical recommendations have been made.</p><p><strong>May 2008 </strong>— minor text update. Issued in June 2008.</p><p><strong>January 2008 </strong>— minor text update to the choice of antihistamines to treat urticaria. Issued in February 2008.</p><p><strong>July 2007 </strong>— minor text update to 'Risk factors for being stung or bitten' section. Issued in August 2007.</p><p><strong>January to April 2007 </strong>— converted from CKS guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. There are no major changes to the recommendations.</p><p><strong>October 2003 </strong>— written. Validated in December 2003 year and issued in February 2004.</p><!-- end field b52e3a75-63b0-4abf-8f1a-6fb7560ec7f3 --><!-- end item afcfeac6-ce7c-40b6-baf3-a51c93a27a0a -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}